Related Experiment Video
Updated: May 16, 2026
07:09
Isolation of Adipose Tissue Immune Cells
Published on: May 22, 2013
Persistent Adipose Inflammation Despite Metabolic Recovery Reveals Tissue-Specific Immunomodulation by Tirzepatide
Mihye Seo1, Maria Averia2, Vivi Julietta2
1Division of Endocrinology and Metabolism, Department of Internal Medicine, Soonchunhyang University Seoul Hospital, Soonchunhyang University College of Medicine, Seoul, Korea.
Endocrinology and Metabolism (Seoul, Korea)
|May 15, 2026
Summary
Tirzepatide aids weight loss but doesn't resolve adipose tissue inflammation or fibrosis. Hepatic inflammation improves, but persistent adipose tissue issues highlight the need for targeted therapies.
Area of Science:
- Metabolic disease research
- Pharmacology
- Immunology
Background:
- Obesity involves chronic adipose tissue inflammation and fibrosis.
- The persistence of these issues during drug-induced weight loss is unclear.
- Tirzepatide, a dual GLP-1/GIP receptor agonist, was studied for its effects on obese mouse adipose tissue.
Purpose of the Study:
- To investigate tirzepatide's impact on adipose tissue inflammation and fibrosis during weight loss.
- To explore the mechanisms behind tirzepatide's tissue-specific effects.
- To identify factors influencing inflammatory persistence in adipose tissue.
Main Methods:
- Obese mice received tirzepatide or vehicle for 25 days.
- Assessed metabolic parameters, inflammation, fibrosis, and macrophage activation via histology, flow cytometry, gene expression, and immunoblotting.
- Conducted in vitro experiments on macrophage activation.
Main Results:
- Tirzepatide reduced weight, adiposity, and improved metabolic parameters.
- Adipose tissue inflammation and fibrosis persisted despite weight loss.
- Hepatic inflammation and fibrosis improved; tirzepatide's anti-inflammatory effects varied with macrophage activation state.
Conclusions:
- Tirzepatide shows tissue-specific effects, improving liver pathology but not adipose tissue inflammation.
- Metabolically activated macrophages may drive persistent inflammation in adipose tissue.
- Targeting macrophage activation and fibrotic remodeling is crucial for durable weight loss benefits.
